Skip to main content
logo
GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
40.75
+1.90 (4.89%)
At close: May 15, 2026, 4:00 PM EDT
41.00
+0.25 (0.61%)
After-hours: May 15, 2026, 7:59 PM EDT

Company Description

GeneDx Holdings Corp., a genomics company, provides genetic testing services.

The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.

It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.

GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

GeneDx Holdings Corp.
GeneDx Holdings logo
CountryUnited States
Founded2017
IndustryDiagnostics & Research
SectorHealthcare
Employees1,300
CEOKatherine Stueland

Contact Details

Address:
North Tower, 6th Floor
Stamford, Connecticut 06902
United States
Phone888 729 1206
Websitegenedx.com

Stock Details

Ticker SymbolWGS
ExchangeNASDAQ
Stock TypeCommon Stock
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code1818331
CUSIP Number81663L200
ISIN NumberUS81663L2007
Employer ID85-1966622
SIC Code8000

Key Executives

NamePosition
Katherine A. StuelandPresident, Chief Executive Officer and Director
Kevin Feeley CPAChief Financial Officer
Dr. Bryan M. Dechairo Ph.D.Chief Operating Officer
Heidi C. Chen J.D.Chief Legal Officer
Jami BiliboacaChief People Officer
Melanie DuquetteChief Growth Officer

Latest SEC Filings

DateTypeTitle
May 15, 2026SCHEDULE 13D/AFiling
May 11, 2026SCHEDULE 13D/AFiling
May 4, 202610-QQuarterly Report
May 4, 20268-KCurrent Report
Apr 30, 2026ARSFiling
Apr 30, 2026DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 30, 2026DEF 14AOther definitive proxy statements
Apr 29, 2026144Filing
Apr 29, 2026144Filing
Mar 2, 20268-KCurrent Report
View All SEC Filings